Event Brief

After our successive IO editions across the globe for the last 7 years, MarketsandMarkets is proud to host the 6th Annual Next Gen Immuno-Oncology Congress to be held on 22nd-23rd June 2023 in Boston, USA

The conference would address the novel case-studies and developments in IO research across the 2 days aiming to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This meeting would also focus on various combination strategies, pre-clinical and translational immuneoncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions.

For more information please contact

Monoclonal and Bispecific Antibodies

• ADCs development Preclinical and Translational Oncology

• Oncology

• Bi-specifics- Preclinical and Translational

• Clinical development

• R&D- Discovery and process

• PKPD/ADME/Tox

• Antibody Engineering

• Antibody therapeutics

• Physio-Chemistry / Synthetic Chemistry and/ Bio conjugation

• Bioanalysis